Kroger Health and Cardio Chek Plus Analyzers Team Up

Kroger Health and PTS Diagnostics have announced that they have a new partnership together. In this partnership, they will introduce CardioChek Plus analyzers.

CardioChek Plus analyzers

CardioChek Plus analyzers are used to provide a quick and accurate test result in as little as 90 seconds.

This battery-powered device easily fits in your hand and uses technology called a reflectance photometry test. The process starts by applying a blood sample to a test strip that is in the analyzer. Once the chemical reaction begins, the test strip will change color according to your blood sugar levels.

The analyzer measures lipid and glucose levels by using electrochemical technology by comparing the color intensity on the strip with the calibration information stored in the MEMo Chip. This will give you a speedy and accurate result

Using the analyzers at Kroger Health clinics and pharmacies will significantly increase how many people both with and without diabetes are receiving preventative health screenings.


Kroger Health

The president of Kroger Health, Colleen Lindolz, stresses that one of the best ways to combat health complications with conditions such as prediabetes and high cholesterol is by “knowing your numbers.” By knowing that you are at risk for certain health conditions, you can actively work on preventing them.

Utilizing a device like the CardioChek Plus in a Kroger clinic and pharmacy not only helps by making the test obtainable to patients, but it also helps eliminate the need for big testing machinery. The analyzer is also one of the most cost-efficient and user-friendly analyzers in the world.

Switching to the simple CardioChek Plus in Kroger Health locations is a significant step in making the proper health care available to those that may not otherwise be able to get the proper tests done. This will help in eliminating preventable disease with early identification and targeting disease progression.

The CardioChek Plus is officially FDA waived and also meets the National Cholesterol Education Program (NCEP) regulations. The final distribution of the analyzers will be done by February 2019.